StonvexLoading…
StonvexStonvexStonvexCore line items from PGNY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $328.50M | $1.29B | $313.35M | $332.87M |
Operating Income | $35.38M | $85.28M | $21.53M | $24.36M |
Net Income | $24.23M | $58.52M | $13.86M | $17.11M |
EPS (Diluted) | $0.29 | $0.65 | $0.15 | $0.19 |
Total Assets | $698.34M | $742.43M | $795.23M | $760.95M |
Total Liabilities | $258.99M | $226.39M | $235.22M | $245.93M |
Cash & Equivalents | $131.61M | $112.24M | $133.98M | $132.51M |
Free Cash Flow OCF − CapEx | $39.60M | $191.78M | $143.19M | $97.21M |
Shares Outstanding | 78.27M | 83.37M | 86.15M | 85.93M |